IT & Data Management
IT & Data Management
Forecasting mRNA Degradation To Enhance Vaccine Stability
Messenger ribonucleic acid (mRNA) as a therapeutic method is gaining traction due to its ease of production and promising results.
mRNA-based vaccines, for example, have been critical in the fight against COVID-19 in many parts of the world. Yet, because...
IT & Data Management
eConsent Trial To Enable Making Patient Partaking Seamless
For the very first time, drug research participants can go on to give digital consent when it comes to their participation. This will take place in the first study that will happen in all Dutch general practitioner practises partnered...
IT & Data Management
Prediction of Enzyme Functions Better Through Key Tools By AI
A novel artificial intelligence tool can help predict the functions of enzymes on the basis of their amino acid sequences, even when the enzymes are unstudied or not clearly understood.
As per the researchers, the AI tool called CLEAN outshines...
IT & Data Management
Citeline Finalist CluePoints Show Advanced AI Capabilities
CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced it has been shortlisted for the 2023 Citeline Awards in the Best Use of Artificial Intelligence in Clinical Trials category.
The...
IT & Data Management
Stem Cell Robots For Cell Therapy To Be Trialled By MHRA, UK
The Medicines and Healthcare Products Regulatory Agency's (MHRA) UK stem cell bank is trailing a new and innovative robot that would grow stem cells.
The MHRA's UK Stem Cell Bank is examining a stem cell propagation robot over a period...
IT & Data Management
Is ChatGPT the next Dr. Google- What does it mean for Business Strategy & Forecasting in Pharmaceuticals?
Sanobar Syed is a leading authority in the field of Pharmaceutical Business strategy and forecasting. She has diverse and deep experience working in generic, innovator and distribution companies in USA, Europe, Canada, and India.
There was a time not long...
IT & Data Management
CAGR of 11% Projected In Bioavailability Enhancement Market
Since more biopharmaceutics classification system- BCS II as well as BCS IV molecules are being evaluated in the early stages of development, one of the market reports has signalled that the bioavailability enhancement market is expected to grow at...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.